You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies
Job Summary
You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies.
Contribute to departmental goals as part of the leadership group; set and implement strategy for accelerated development of oral solid dosage forms, including capability building and strategic partnerships.
Partner closely with analytical sciences, clinical supply, process engineering, regulatory and external CDMOs/CROs to remove barriers, manage interfaces and deliver business value.
Matching Summary
You will guide a team focused on oral solid dosage forms for Phase I and II, including enabling formulations for poorly soluble compounds—work that directly influences how quickly patients see the benefit of breakthrough therapies.
Skills & Requirements
Must-have
early product development
oral solid dosage forms
poorly soluble compounds
team leadership and development
digital, predictive and automated approaches
regulatory submissions
Nice-to-have
scientific curiosity meets bold execution
kindness alongside ambition
thoughtful challenge
strategic external collaborators
Key Requirements
at least 10 years’ experience within the industry
BSc, MSc, PhD or equivalent
proven record of delivery in pharmaceutical development
demonstrated success leading teams of scientists
knowledge of and practical experience of quality, SHE and regulatory requirements